טוען...
The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular (CV) risk markers. In this study our aim was to assess the effects of six months treatment with liraglutide 1.8 mg od on obesity, and CV risk markers, particularly platelet function, in young obese w...
שמור ב:
| הוצא לאור ב: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4389314/ https://ncbi.nlm.nih.gov/pubmed/25880805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-015-0005-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|